INSM Q4 2021 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$56M+35.5% YoY

Gross Profit

$43M76.3% margin

Operating Income

-$99M-176.5% margin

Net Income

-$113M-201.3% margin

EPS (Diluted)

$-0.95

QoQ Revenue Growth

+20.0%

Cash Flow

Operating Cash Flow

-$84M

Free Cash Flow

-$85M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$833M

Stockholders' Equity

$410M

Cash & Equivalents

$717M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$56M	$41M	+35.5%
Gross Profit	$43M	$31M	+40.2%
Operating Income	-$99M	-$95M	-4.8%
Net Income	-$113M	-$102M	-10.5%